Drug Co. InvaTech Says Loan Terms Pushed It Into Ch. 11

By Emlyn Cameron · February 20, 2025, 2:57 PM EST

InvaTech Pharma Solutions LLC, a New Jersey-based developer of generic prescription drugs, chose to enter Chapter 11 with up to $50 million in debt in part because some of its secured...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login